Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Compliance With Once Daily Glaucoma Medication

This study has been completed.
Sponsor:
Collaborators:
Johns Hopkins University
University of Pennsylvania
Information provided by (Responsible Party):
Alcon Research
ClinicalTrials.gov Identifier:
NCT00333463
First received: June 1, 2006
Last updated: November 17, 2016
Last verified: March 2010

June 1, 2006
November 17, 2016
June 2006
September 2007   (final data collection date for primary outcome measure)
Not Provided
Not Provided
Complete list of historical versions of study NCT00333463 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Compliance With Once Daily Glaucoma Medication
Compliance With Once Daily Glaucoma Medication
A study to examine patient compliance with once daily glaucoma medication
Not Provided
Observational
Time Perspective: Retrospective
Not Provided
Not Provided
Probability Sample
Primary open angle glaucoma or ocular hypertension patients
Compliance
Behavioral: Intervention
The intervention group watched an educational video, reviewed current barriers to drop-taking and possible solutions with a study coordinator, received regular phone call reminders, and had audible and visible reminders activated on their DA devices.
  • Intervention group
    The intervention group watched an educational video, reviewed current barriers to drop-taking and possible solutions with a study coordinator, received regular phone call reminders, and had audible and visible reminders activated on their DA devices.
    Intervention: Behavioral: Intervention
  • Non-Intervention Group
    The control group was told to take drops as prescribed and received no additional intervention.
Okeke CO, Quigley HA, Jampel HD, Ying GS, Plyler RJ, Jiang Y, Friedman DS. Adherence with topical glaucoma medication monitored electronically the Travatan Dosing Aid study. Ophthalmology. 2009 Feb;116(2):191-9. doi: 10.1016/j.ophtha.2008.09.004.

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
700
September 2007
September 2007   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • Primary open angle glaucoma or ocular hypertension patients

Exclusion Criteria:

Both
Child, Adult, Senior
No
Contact information is only displayed when the study is recruiting subjects
United States
 
NCT00333463
CMS-06-03
Not Provided
Not Provided
Not Provided
Alcon Research
Alcon Research
  • Johns Hopkins University
  • University of Pennsylvania
Study Director: David Friedman, MD Study Director
Alcon Research
March 2010

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP